content: Total Number of Pages:  6
  Exhibit Index on Sequential Page No.:  3
  
  
  
  
                         SECURITIES AND EXCHANGE COMMISSION
  
                               Washington, D.C. 20549
  
  
  
  
                                      FORM 8-K
  
                                   CURRENT REPORT
  
  
  
  
                         Pursuant to Section 13 or 15(d) of
                         the Securities Exchange Act of 1934
  
  
  Date of Report (Date of earliest event reported):      June 25, 1996
                                                        ---------------
  
  
                                  ORNDA HEALTHCORP
               (Exact name of registrant as specified in its charter)
  
  
                                      DELAWARE
                   (State or other jurisdiction of incorporation)
  
  
         1-11591                                           75-1776092
  (Commission File Number)                      (IRS Employer Identification No.)
  
  3401 West End Avenue, Nashville, Tennessee                 37203
  (Address of principal executive office)                  (Zip Code)
  
  Registrant's telephone number, including area code:  (615) 383-8599
  <PAGE>
  Item 5.   Other Events.
  
            The Registrant hereby incorporates by reference the information about
  the Registrant set forth in Exhibit 99 attached hereto.
  
  Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits.
  
            (c)  Exhibits.
  
                 99   The first two pages of Registrant's news release dated
                      June 25, 1996.
  
  
                                     SIGNATURES
  
            Pursuant to the requirements of the Securities Exchange Act of 1934,
  the Registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
                                          ORNDA HEALTHCORP
  
                                          (Signature)
                                          Ronald P. Soltman
                                          Senior Vice President
  
  Date:    June 25, 1996
                                        -2-
  <PAGE>
                                    EXHIBIT INDEX
  
                                                                       Sequential
  No.  Subject Matter                                                    Page No.
  
  99   The first two pages of Registrant's news release dated June 25, 1996...  4
  
                                        -3-
  
  <PAGE>
                                                                        Exhibit 99
  
  
                                        -4-
  <PAGE>
  [OrNda Letterhead]
  
  FOR IMMEDIATE RELEASE:
  
  Contact:          Keith B. Pitts
                    Executive Vice President and Chief Financial Officer
                      or
                    Thomas A. Bartels
                    Director of Investor Relations
                    OrNda HealthCorp
                    (615) 383-8599
  
                             ORNDA NET INCOME UP 32.6%
      -----------------------------------------------------------------------
                             THIRD QUARTER EPS OF $0.49
  
  NASHVILLE, Tennessee (June 25, 1996) -- OrNda HealthCorp (NYSE:ORN) today
  reported that net income for the three months ended May 31, 1996, increased
  32.6% to $29.3 million from $22.1 million in the third quarter of last year.
  Third quarter earnings from continuing operations were $29.3 million, up 36.2%
  from third quarter 1995 earnings from continuing operations of $21.5 million.
  Earnings per share rose to $0.49 on 60.4 million weighted average common and
  common equivalent shares for the third quarter ended May 31, 1996, compared with
  $0.47 on 45.6 million weighted average common and common equivalent shares for
  the same period last year. The majority of the increase in weighted average
  common and common equivalent shares is due to the issuance of 11.5 million
  common shares and the conversion of 1.4 million shares of convertible preferred
  stock to common shares in November 1995.
  
           Revenue for the third quarter of fiscal 1996 was $557.9 million
  compared with $497.9 million in last year's third quarter. OrNda's EBITDA margin
  improved to 16.3% for the third quarter of fiscal 1996 compared with 14.4% in
  the same period last year.
  
            Net income increased to $76.7 million for the first nine months of
  fiscal 1996 compared with $55.4 million in the same period of fiscal 1995,
  representing an increase of 38.5%. Income from continuing operations for
  the nine months ended May 31, 1996, increased to $76.7 million from $54.8
  million for the same period in the prior year, an increase of 40.0%.
  Earnings per share for the nine months ended May 31, 1996, rose to $1.35
  from $1.20 for the same period last year. For the nine months ended May 31,
  1996, revenues were $1.6 billion compared with $1.4 billion last year. The
  Company's EBITDA margin increased to 15.6% from 14.5% for the same
  
                                      - MORE -
  
  <PAGE>
  ORN Reports Third Quarter Results
  Page 2
  June 25, 1996
  
  nine-month period last year. On a fully diluted basis, earnings per share for
  the nine months ended May 31, 1996 and 1995, were $1.34 and $1.20, respectively.
  
           For the nine months ended May 31, 1996, on a same hospital basis,
  revenues increased by 6.9%, admissions increased by 2.7%, and adjusted
  admissions increased by 6.1% over the prior year. For the third quarter, same
  hospital revenues rose by 4.7% compared with the same period last year. Same
  hospital admissions for the quarter were relatively flat and adjusted admissions
  rose by 2.9% over the prior year.
  
           Charles N. Martin, Jr., chairman, president and chief executive officer
  of OrNda HealthCorp, said, "We continue to be successful in obtaining more
  managed care business, particularly capitated contracts. Our success in managing
  medical utilization under these contracts has contributed positively to our
  operating margins. I am pleased to report that we are well positioned in our
  markets to implement our operational strategy which includes expansion of
  outpatient services and the continued development of integrated health care
  delivery networks."
  
           As previously announced, OrNda has signed definitive agreements to
  purchase The Fallon Healthcare System's Saint Vincent Healthcare System in
  Worcester, Massachusetts, and Centinela Hospital Medical Center in Inglewood,
  California. A letter of intent has also been signed with Cypress Fairbanks
  Medical Center in Houston, Texas. These three acquisitions are expected to add
  approximately $400 million in annual revenue to OrNda's operations.
  
           OrNda HealthCorp, based in Nashville, Tennessee, is the third largest
  investor-owned hospital management company in the United States. It is a leading
  provider of health care services, delivering a broad range of inpatient and
  outpatient health care services principally through the operation of 48
  hospitals located in urban and suburban communities in 14 states. For additional
  information on the Company, visit OrNda HealthCorp's Web site:
  http://www.orndahealth.com
  
  Additional Media Contact:     Paula Lovell
                                Lovell Communications Inc.
                                (615) 297-7766
                                       -###-
metadata_documents: [{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 7218}]
metadata_filer: {"company-data": {"conformed-name": "ORNDA HEALTHCORP", "cik": "0000719242", "assigned-sic": "8060", "irs-number": "751776092", "state-of-incorporation": "DE", "fiscal-year-end": "0831"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11591", "film-number": "96586093"}, "business-address": {"street1": "3401 W END AVE STE 700", "city": "NASHVILLE", "state": "TN", "zip": "37203-1042", "phone": "6153838599"}, "mail-address": {"street1": "3401 WEST END AVE", "street2": "SUITE 700", "city": "NASHVILLE", "state": "TN", "zip": "37203-1042"}, "former-company": {"former-conformed-name": "REPUBLIC HEALTH CORP", "date-changed": "19920415"}}
text: Total Number of Pages:  6
  Exhibit Index on Sequential Page No.:  3
  
                         SECURITIES AND EXCHANGE COMMISSION
  
                               Washington, D.C. 20549
  
                                      FORM 8-K
  
                                   CURRENT REPORT
  
                         Pursuant to Section 13 or 15(d) of
                         the Securities Exchange Act of 1934
  
  Date of Report (Date of earliest event reported):      June 25, 1996
                                                        ---------------
  
                                  ORNDA HEALTHCORP
               (Exact name of registrant as specified in its charter)
  
                                      DELAWARE
                   (State or other jurisdiction of incorporation)
  
         1-11591                                           75-1776092
  (Commission File Number)                      (IRS Employer Identification No.)
  
  3401 West End Avenue, Nashville, Tennessee                 37203
  (Address of principal executive office)                  (Zip Code)
  
  Registrant's telephone number, including area code:  (615) 383-8599
  Item 5.   Other Events.
  
            The Registrant hereby incorporates by reference the information about
  the Registrant set forth in Exhibit 99 attached hereto.
  
  Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits.
  
            (c)  Exhibits.
  
                 99   The first two pages of Registrant's news release dated
                      June 25, 1996.
  
                                     SIGNATURES
  
            Pursuant to the requirements of the Securities Exchange Act of 1934,
  the Registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
                                          ORNDA HEALTHCORP
  
                                          (Signature)
                                          Ronald P. Soltman
                                          Senior Vice President
  
  Date:    June 25, 1996
                                        -2-
  EXHIBIT INDEX
  
                                                                       Sequential
  No.  Subject Matter                                                    Page No.
  
  99   The first two pages of Registrant's news release dated June 25, 1996...  4
  
                                        -3-
  Exhibit 99
  
                                        -4-
  [OrNda Letterhead]
  
  FOR IMMEDIATE RELEASE:
  
  Contact:          Keith B. Pitts
                    Executive Vice President and Chief Financial Officer
                      or
                    Thomas A. Bartels
                    Director of Investor Relations
                    OrNda HealthCorp
                    (615) 383-8599
  
                             ORNDA NET INCOME UP 32.6%
      -----------------------------------------------------------------------
                             THIRD QUARTER EPS OF $0.49
  
  NASHVILLE, Tennessee (June 25, 1996) -- OrNda HealthCorp (NYSE:ORN) today
  reported that net income for the three months ended May 31, 1996, increased
  32.6% to $29.3 million from $22.1 million in the third quarter of last year.
  Third quarter earnings from continuing operations were $29.3 million, up 36.2%
  from third quarter 1995 earnings from continuing operations of $21.5 million.
  Earnings per share rose to $0.49 on 60.4 million weighted average common and
  common equivalent shares for the third quarter ended May 31, 1996, compared with
  $0.47 on 45.6 million weighted average common and common equivalent shares for
  the same period last year. The majority of the increase in weighted average
  common and common equivalent shares is due to the issuance of 11.5 million
  common shares and the conversion of 1.4 million shares of convertible preferred
  stock to common shares in November 1995.
  
           Revenue for the third quarter of fiscal 1996 was $557.9 million
  compared with $497.9 million in last year's third quarter. OrNda's EBITDA margin
  improved to 16.3% for the third quarter of fiscal 1996 compared with 14.4% in
  the same period last year.
  
            Net income increased to $76.7 million for the first nine months of
  fiscal 1996 compared with $55.4 million in the same period of fiscal 1995,
  representing an increase of 38.5%. Income from continuing operations for
  the nine months ended May 31, 1996, increased to $76.7 million from $54.8
  million for the same period in the prior year, an increase of 40.0%.
  Earnings per share for the nine months ended May 31, 1996, rose to $1.35
  from $1.20 for the same period last year. For the nine months ended May 31,
  1996, revenues were $1.6 billion compared with $1.4 billion last year. The
  Company's EBITDA margin increased to 15.6% from 14.5% for the same
  
                                      - MORE -
  ORN Reports Third Quarter Results
  Page 2
  June 25, 1996
  
  nine-month period last year. On a fully diluted basis, earnings per share for
  the nine months ended May 31, 1996 and 1995, were $1.34 and $1.20, respectively.
  
           For the nine months ended May 31, 1996, on a same hospital basis,
  revenues increased by 6.9%, admissions increased by 2.7%, and adjusted
  admissions increased by 6.1% over the prior year. For the third quarter, same
  hospital revenues rose by 4.7% compared with the same period last year. Same
  hospital admissions for the quarter were relatively flat and adjusted admissions
  rose by 2.9% over the prior year.
  
           Charles N. Martin, Jr., chairman, president and chief executive officer
  of OrNda HealthCorp, said, "We continue to be successful in obtaining more
  managed care business, particularly capitated contracts. Our success in managing
  medical utilization under these contracts has contributed positively to our
  operating margins. I am pleased to report that we are well positioned in our
  markets to implement our operational strategy which includes expansion of
  outpatient services and the continued development of integrated health care
  delivery networks."
  
           As previously announced, OrNda has signed definitive agreements to
  purchase The Fallon Healthcare System's Saint Vincent Healthcare System in
  Worcester, Massachusetts, and Centinela Hospital Medical Center in Inglewood,
  California. A letter of intent has also been signed with Cypress Fairbanks
  Medical Center in Houston, Texas. These three acquisitions are expected to add
  approximately $400 million in annual revenue to OrNda's operations.
  
           OrNda HealthCorp, based in Nashville, Tennessee, is the third largest
  investor-owned hospital management company in the United States. It is a leading
  provider of health care services, delivering a broad range of inpatient and
  outpatient health care services principally through the operation of 48
  hospitals located in urban and suburban communities in 14 states. For additional
  information on the Company, visit OrNda HealthCorp's Web site:
  http://www.orndahealth.com
  
  Additional Media Contact:     Paula Lovell
                                Lovell Communications Inc.
                                (615) 297-7766
                                       -###-